Receive consulting resources in your inbox

Peloton Equity: Investment Strategy, Funds, Portfolio Companies, and Firm Profile

1. What Is Peloton Equity?

Peloton Equity is a healthcare-focused private equity firm that supplies growth capital to businesses with established commercial propositions. It was formed in 2014 by Carlos Ferrer and Theodore “Ted” Lundberg as the successor firm to Ferrer Freeman & Company. Its headquarters are in Greenwich, Connecticut, and its principal investment market is the United States.

The firm invests across healthcare technology, provider and payor services, pharmaceutical services, and related products and tools. Its transactions include growth financings, majority recapitalizations, and the development of operating platforms alongside management teams and other investors. Healthcare specialization, rather than a single ownership format, connects these activities.

For this directory, Peloton fits the growth-equity portion of Growth equity and venture crossover, together with Sector-specialist private equity and Lower-middle-market investors. Its geography group is North America, with a specifically U.S.-centered investment footprint. These are editorial classifications, not claims about returns, fundraising strength, or comparative standing.

2. Peloton Equity at a Glance

Firm name
Peloton Equity, LLC.
Firm type
Healthcare-specialist private equity and growth-capital investor.
Founded
2014; the firm’s first investment announcement identifies an August launch.
Founders
Carlos Ferrer and Theodore “Ted” Lundberg.
Headquarters
Greenwich, Connecticut, United States.
Parent organization
A separate parent organization was not verified. Ferrer Freeman & Company is the predecessor, not a verified current parent.
Main investment markets
United States.
Geography group
North America.
Directory segments
Growth equity and venture crossover; Sector-specialist private equity; Lower-middle-market investors.
Principal strategy
Growth capital for commercially established healthcare businesses.
Ownership approach
Significant investment positions, including documented majority transactions and retained ownership following partial realizations.
Typical company profile
Healthcare businesses generally generating $10 million to $200 million in revenue at investment.
Sector focus
Healthcare IT, provider services, payor services, pharmaceutical services, and life-sciences tools.
Major identifiable funds
Peloton Equity II, L.P.; earlier vehicle Peloton Equity I, L.P. Their identification does not establish remaining investment capacity.
Current status
Operating healthcare investment firm.
Official website
Peloton Equity Official Website

The founding, strategy, ownership examples, and fund descriptions above distinguish the management organization from its investment vehicles and predecessor experience.

3. Who Founded Peloton Equity, and How Is the Firm Organized?

Carlos Ferrer and Ted Lundberg founded Peloton Equity after working together at Ferrer Freeman & Company, commonly abbreviated FFC. Ferrer had co-founded FFC in 1995 after serving as a managing director at Credit Suisse First Boston, where he established its healthcare investment banking group. Lundberg was previously an FFC partner and began his career in healthcare investment banking at Donaldson, Lufkin & Jenrette. Peloton currently identifies Lundberg as Managing Partner and Ferrer as Founding Partner.

Peloton’s legal disclosures describe a 2014 investment-team spinout. Early fund documents identify a Greenwich, Connecticut address, establishing an early operating connection to the city. The reviewed evidence does not separately establish a different founding location. Peloton Equity I was organized in Delaware, but that legal jurisdiction should not be confused with the firm’s operating base.

The investment organization includes sector-oriented partners. Justin Yang specializes in pharmaceutical services and healthcare IT; Michael O’Rourke specializes in provider and payor services. Keith Longson holds the title Partner, Portfolio Value Creation. Investment professionals, operating partners, and an advisory board therefore represent distinct parts of the firm’s resources.

Transaction disclosures identify Ferrer and Lundberg as managing members of Peloton Equity GP, LLC. That establishes their governance relationship to the general partner, not a complete ownership breakdown of the management company. FFC’s historic funds also remain separate vehicles, even where Peloton team members continued managing predecessor investments.

4. What Is the History of Peloton Equity?

  1. Predecessor experience and the 2014 launch. Peloton developed from the healthcare investing experience of professionals at Ferrer Freeman & Company. Its legal disclosures describe an investment-team spinout in 2014, while its first company announcement places the launch in August. This is the beginning of Peloton’s own operating history, rather than the beginning of its founders’ healthcare careers.
  2. First investment in HealthPlanOne. In December 2014, Peloton announced that it had invested growth capital and partnered with management to acquire a majority stake in HealthPlanOne. The company’s technology-enabled health-insurance marketing and distribution business established an early example of Peloton’s interest in commercially developed healthcare services.
  3. Platform development and pharmaceutical services in 2019. Peloton and Blue Wolf Capital partnered with a management team to launch ClearSky Health, focused on inpatient rehabilitation and related post-acute services. Separately, Peloton participated in a completed AeroSafe Global growth financing intended to support commercial expansion, additional services, and new geographies. These investments broadened its exposure beyond healthcare software and insurance distribution.
  4. Fund II and the AeroCare transaction in 2021. Peloton announced the final close of its second fund in February 2021. That month, AeroCare’s acquisition by AdaptHealth also completed. The consideration included cash and AdaptHealth shares, illustrating why a strategic sale and a complete investor exit are not automatically the same event.
  5. Life-sciences tools and provider workflow technology. Peloton completed a growth recapitalization of Grenova in March 2022, partnering with management and other investors. In January 2024, it closed an investment in OnPoint Healthcare Partners, which combines technology and services to address provider administrative work.
  6. Developments in 2025 and 2026. Peloton led Ria Health’s completed Series B growth-equity financing in March 2025 and announced Arcadia’s proposed majority ownership transition to Nordic Capital in July. Grenova subsequently acquired Peak Robotics and, in March 2026, described a broader laboratory automation platform backed by Peloton.

5. What Investment Strategies Does Peloton Equity Pursue?

Peloton’s central strategy is growth capital within healthcare. The firm describes its investment stage as “post-venture, pre-buyout”: businesses have demonstrated market adoption but still need capital, organizational development, or commercial resources to reach greater scale. That positioning supports a growth-equity classification without making Peloton a conventional seed-stage venture investor.

Its ownership approach is not captured adequately by a control-only label. HealthPlanOne’s original investment involved a majority stake acquired alongside management. Grenova’s recapitalization also involved a majority position acquired by Peloton, management, and other investors together. The latter disclosure does not establish that Peloton alone owned a majority.

Other transactions are syndicated growth financings. Peloton invested alongside additional healthcare and financial investors in AeroSafe Global and led Ria Health’s Series B round with existing investors participating. Those disclosures establish the financing format, but a funding-round label alone does not establish Peloton’s exact ownership percentage.

Platform formation is another documented route. ClearSky Health was launched with an experienced management team and a fellow sponsor to develop and acquire rehabilitation businesses. OnPoint’s financing, by contrast, supported technology development, sales and marketing, and client services within an existing company.

Analytically, these transactions suggest flexibility in how Peloton finances growth. The consistent feature is a healthcare business-building thesis, rather than a uniform requirement for full ownership, an early venture round, or a leveraged acquisition. That interpretation should not be treated as a published promise to accept every transaction structure.

6. What Funds Does Peloton Equity Manage?

Peloton’s publicly identifiable fund structure includes successive limited partnerships and company-specific investment vehicles. The management firm, general partner, underlying funds, and corporate holdings are distinct entities. Two named fund generations can be established directly: Peloton Equity I, L.P. and Peloton Equity II, L.P.

Peloton Equity I, L.P.

Fund I was organized in 2014. A securities-offering amendment filed on February 17, 2016 reported $48.092 million in total securities sold, denominated in U.S. dollars, with no remaining amount to be sold in that reported offering. This is the filing’s offering measurement, not a current AUM figure or an independently verified final-close announcement.

Peloton Equity II, L.P.

On February 11, 2021, Peloton announced Fund II’s final close with $152.25 million in limited-partner and general-partner commitments. The announcement identified ClearSky Health and AeroSafe Global among investments already made from the fund. It described capital for new investments and follow-on financing at that time; it does not establish remaining capacity in October 2026.

Company-specific vehicles and attribution

ZeroFox ownership disclosures identified both Peloton Equity I, L.P. and Peloton ID Experts, LLC as shareholders before its 2024 take-private. The latter is retained as a separately identified vehicle rather than being silently folded into Fund I. Specific fund attribution for other companies should not be inferred from their acquisition dates.

A later named flagship final close was not verified for this profile. Nor are company financing totals treated as Peloton fund commitments or individual investment tickets: AeroSafe’s financings, for example, included several investors.

7. What Types of Companies Does Peloton Equity Invest In?

Peloton generally describes its target companies as healthcare businesses with $10 million to $200 million in revenue at investment. Its stated criteria emphasize a capable management team, a substantial market opportunity, and a business model capable of meaningful expansion. This is a typical company profile, not proof that every investment satisfies the same financial thresholds.

The portfolio shows several business models rather than a single company archetype. OnPoint supplies technology-enabled administrative and workflow services to healthcare providers. AeroSafe offers outsourced cold-chain packaging and logistics for temperature-sensitive pharmaceutical and related products. ClearSky operates in inpatient rehabilitation and post-acute care.

Ownership situations can include a recapitalization with meaningful continuing management ownership. Grenova’s completed transaction expressly retained a significant stake for its founder, other management, and certain existing shareholders. HealthPlanOne’s original majority investment similarly involved a partnership with management rather than the replacement of the operating organization.

Peloton can also back an executive-led platform with a plan to develop or acquire operating assets, as ClearSky demonstrates. That differs from assuming every investment is the purchase of a mature, standalone business with an unchanged operating footprint.

The reviewed evidence does not establish a standard Peloton equity-ticket range, enterprise-value threshold, or universal leverage requirement. It also does not justify describing corporate carve-outs or public-to-private transactions as the firm’s principal origination channels. The more defensible description is commercially established healthcare companies requiring growth capital and company-building support.

8. Which Industries Does Peloton Equity Focus On?

Healthcare is Peloton’s organizing sector, but its exposure spans businesses that deliver care, support healthcare organizations, distribute insurance, and supply the pharmaceutical and laboratory ecosystem. Its partner specializations reinforce this breadth within a single industry: healthcare IT and pharmaceutical services sit alongside provider and payor services.

  • Healthcare information technology. OnPoint combines software-enabled workflows and services for provider organizations. Arcadia’s historical investment relationship adds healthcare data integration and analytics exposure. These are healthcare-specific applications of technology, not evidence of a general software mandate.
  • Post-acute care. ClearSky Health provides inpatient rehabilitation and related services. Its platform-development model gives Peloton exposure to the delivery of care, rather than only the sale of software or equipment to providers.
  • Durable medical equipment. AeroCare, acquired by AdaptHealth in 2021, provided home oxygen and sleep-therapy services and equipment. This is a documented historical operating-company exposure; it is not presented as a separate current AeroCare platform.

Additional areas include health-insurance distribution through HealthPlanOne, alcohol-use-disorder telehealth through Ria Health, pharmaceutical cold-chain services through AeroSafe, and laboratory tools and automation through Grenova. Grenova’s development shows that healthcare specialization can include enabling infrastructure used by life-sciences organizations, not just patient-facing businesses.

9. Where Does Peloton Equity Invest?

Peloton is headquartered in Greenwich, Connecticut, and its principal investment market is the United States. Its headquarters location identifies the investment organization’s base, not a restriction to companies in Connecticut or the surrounding region.

Documented investments illustrate a geographically dispersed U.S. footprint. ClearSky was launched from Austin, Texas; AeroSafe’s investment announcement identified Rochester, New York; Grenova’s recapitalization concerned a Richmond, Virginia business; and OnPoint’s financing announcement was issued from Dallas. These locations describe particular businesses at the relevant announcement dates, not additional Peloton offices.

For the directory, North America is the appropriate geography group because the United States falls within that region. The broader regional label does not independently establish a Canadian or Mexican investment program. Likewise, a company’s national customer coverage is different from the investor’s geographic mandate.

Some portfolio businesses have international commercial ambitions. AeroSafe’s 2019 financing supported expansion into new geographies, while Grenova’s 2022 recapitalization contemplated building its global presence. These are portfolio-company growth plans, not evidence that Peloton operates a global network of investment offices or manages dedicated non-U.S. regional funds.

10. How Does Peloton Equity Seek to Create Value?

Peloton describes a growth-oriented playbook covering management recruitment, governance, reporting, data-driven decisions, technology strategy, commercial expansion, and acquisitions. Its Peloton Nation network supplies healthcare expertise for investment themes, diligence, and portfolio support. These are firm-described resources and approaches, not independently established outcomes at every investment.

The organization also identifies a dedicated Portfolio Value Creation partner, Keith Longson. That role is distinct from the wider operating-partner and advisory resources. The distinction matters because a named internal responsibility does not mean every specialist capability is delivered by a permanent in-house team.

Documented operating relationships provide more specific examples. OnPoint’s current leadership material identifies Sean Carroll as an operating partner at Peloton who supports portfolio businesses with strategic and operational guidance. OnPoint announced his appointment as CEO in October 2025 alongside a practice-management-as-a-service offering. The evidence establishes involvement and an announced operating model, not independently validated AI productivity results.

Grenova provides a separate example of operating expertise and platform expansion. Its March 2026 announcement identified Ted Hull as CEO, described his work with Peloton as an operating partner, and connected Grenova with Peak Robotics and Peak Analysis & Automation. Its earlier acquisition of Peak Robotics added engineering and laboratory automation capabilities.

Peloton also describes Arcadia’s historical development from a services-heavy business into a recurring-revenue software platform. That account illustrates the type of business-model evolution the firm seeks, but does not isolate Peloton’s contribution from management execution or other investors’ support.

11. What Types of Business Situations May Fit Peloton Equity?

The following situations appear consistent with documented transactions. They are analytical interpretations, not eligibility rules, investment advice, or evidence of current investment appetite.

  • A commercially established technology business needing scale. OnPoint’s financing supported product development, sales and marketing, and client services. A healthcare business facing similar growth-resource requirements may resemble this documented transaction, although resemblance does not establish investor interest.
  • A founder-led business seeking capital while retaining ownership. Grenova’s recapitalization combined new investment with a significant continuing stake for its founder, management, and certain shareholders. This supports founder-partnership situations rather than an assumption that Peloton always requires a complete sale.
  • An experienced executive team building a care-delivery platform. ClearSky’s launch involved management, Peloton, and another sponsor, with plans to develop and acquire rehabilitation operations. The relevant situation is platform construction, not merely refinancing an unchanged company.
  • A healthcare service expanding distribution or coverage. Ria’s financing supported its clinical model, payor coverage, and commercial efforts. AeroSafe’s investment supported new services and geographic expansion. Both illustrate growth funding tied to identifiable operating priorities.

Actual fit would depend on the company, transaction structure, management alignment, and investment review. The examples should not be converted into a guarantee of suitability.

12. What Distinguishes Peloton Equity?

Four characteristics help explain Peloton’s investment proposition without implying superior performance.

  • Healthcare continuity across organizations. The founders and several investment professionals worked at FFC before Peloton. This creates continuity in sector experience, but predecessor investments remain distinct from investments made by Peloton’s own funds. The team’s longer history should not be mistaken for the age or size of the current firm.
  • A commercially developed growth stage. Peloton’s stated positioning between venture development and traditional buyouts emphasizes companies with demonstrated business models that still require substantial scaling. Analytically, this separates its proposition from both seed financing and a control-only acquisition model.
  • Multiple routes to financing growth. Majority recapitalizations, syndicated growth rounds, and executive-led platform formation all appear in documented transactions. This is observable transaction diversity, not proof that every ownership structure is available for every company.
  • Operating relationships that can extend into executive roles. The documented involvement of Peloton-associated operators at OnPoint and Grenova gives concrete examples of company-building support. It does not establish uniform deployment across the portfolio or a quantified portfolio-wide operating benefit.

13. How Should Peloton Equity Be Understood Today?

As of the October 13, 2026 review, Peloton should be understood as a U.S.-centered healthcare growth-capital firm with roots in FFC’s investment team. Its own organization dates to 2014. The distinction between those two histories is central to interpreting its experience and avoiding the attribution of all predecessor investments to Peloton funds.

The core proposition remains healthcare business development. Recent documented activity includes Ria’s growth-equity financing, OnPoint’s technology and operating-model development, and Grenova’s expansion into laboratory automation. These examples show a broader set of healthcare-enabling business models than a narrow focus on traditional care-provider buyouts. They do not establish a portfolio-wide AI transformation or uniform operating results.

Ownership must be interpreted company by company. Nordic Capital now lists Arcadia in its portfolio, while Peloton’s public sale announcement does not resolve any retained exposure. ZeroFox’s completed cash take-private is a different case from an IPO or share-for-share sale. The portfolio classifications therefore avoid treating every strategic transaction as a full realization.

The financial reference points in this profile have their own dates: Fund I’s offering measurement is from 2016, and Fund II’s final-close commitments were announced in 2021. Neither is a current firm-wide AUM measurement or a statement about available capital today.

Inclusion in Umbrex’s Top 1000 Global Private Equity Firms research collection identifies the profile’s directory context. It is not a verified ranking or an endorsement of performance, prestige, investment quality, or suitability.

14. Frequently Asked Questions

Is Peloton Equity a private equity firm or a venture capital firm?

Peloton describes itself as a private equity firm focused on healthcare growth capital. Its commercial-stage positioning and documented majority recapitalizations support a growth-equity classification, rather than describing it principally as a seed-stage venture investor.

Who founded Peloton Equity, and when?

Carlos Ferrer and Ted Lundberg founded Peloton in 2014 following their work at Ferrer Freeman & Company. The firm’s first investment announcement identifies an August 2014 launch, while current biographies distinguish Ferrer’s and Lundberg’s respective roles.

Where is Peloton Equity based, and where does it invest?

The firm is based in Greenwich, Connecticut. Its principal investment market is the United States, with documented companies in several states. The directory’s North America classification does not independently establish a Canadian or Mexican investment mandate.

Does Peloton Equity require majority ownership?

A universal majority-ownership requirement was not verified. Peloton has participated in majority transactions, syndicated growth financings, and retained exposure after partial realizations. A consortium’s majority stake should not be confused with a majority owned by Peloton alone.

What is the verified size of Peloton Equity Fund II?

Peloton announced Fund II’s final close on February 11, 2021 with $152.25 million in limited-partner and general-partner commitments. That dated commitment amount is not equivalent to current firm AUM, invested capital, or remaining investment capacity.

Does the portfolio table cover every investment made by the team?

No. It is a selective list of Peloton-sponsored corporate investment relationships. FFC predecessor holdings are not automatically included, and ownership uncertainty is preserved where the reviewed evidence does not resolve the firm’s remaining exposure.